PKC Inhibition and Diabetic Complications

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 2, 2008-06 ,pp. : 72-78

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Fat as New Diagnostic Tool and Potential Therapeutic Target for Obesity Management and Treatment

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 162-165

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approach on AGE-RAGE Interaction and Its Function in Diabetic Inflammation Process

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 241-247

Bentham Science Publishers

Access to resources Recommend Favorite

HDL - Cholesterol: The New Target for Treatment

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 2, 2010-06 ,pp. : 153-160

Bentham Science Publishers

Access to resources Recommend Favorite

Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting: Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique

By  

Recent Patents on Drug Delivery & Formulation, Vol. 10, Iss. 2, 2016-08 ,pp. : 82-129

Bentham Science Publishers

Access to resources Recommend Favorite